Identification and characterization of degradation products of Nateglinide

https://doi.org/10.53730/ijhs.v6nS2.8413

Authors

  • Pratima Kumari Chitkara College of Pharmacy, Chitkara University, Rajpura- 140401, India
  • Ritchu Babbar Chitkara College of Pharmacy, Chitkara University, Rajpura- 140401, India
  • Ravinder Singh Chitkara College of Pharmacy, Chitkara University, Rajpura- 140401, India
  • Balraj Saini Chitkara College of Pharmacy, Chitkara University, Rajpura- 140401, India

Keywords:

nateglinide, LC-MS-QTOF, forced degradation, mass fragmentation, impurities

Abstract

Nateglinide (NTG) was evaluated under a variety of ICH-recommended forced degradation settings and found to be degraded under acid and alkali hydrolysis but stable under other forced degradation conditions. Under acid hydrolytic conditions, three degradation impurities (I-III) were produced. All three contaminants were separated using a C-18 column with ammonium acetate buffer (20 mM), methanol, and acetonitrile as mobile phases provided in isocratic mode, and characterisation was done utilising +ESI-MSn and LC-MS-QTOF investigations. All three degrading impurities (I-III) were discovered to be novel. The most likely pathways of deterioration were presented and debated. 

Downloads

Download data is not yet available.

References

Karasakal, A. and Gürkan, Y.Y., 2022. Forced Degradation Studies of Nateglinide by the First-Order Derivative Spectrophotometric Method and the Density Functional Theory of the Nateglinide Molecule. J. Appl. Spectrosc., 88(6), pp.1183-1188.

Dunn, C. J., & Faulds, D. 2000. Nateglinide. Drugs, 60(3), pp. 607–617.

Sireesha, M., Chandan, R.S., Gurupadayya, B.M. and Shravya, A., 2011. Spectrophotometric determination of Nateglinide using 2, 4-dinitrophenyl hydrazine and potassium ferricyanide in pharmaceutical dosage form. Der Pharma Chemica, 3(1), pp.497-06.

Keilson, L., Mather, S., Walter, Y.H., Subramanian, S. and McLeod, J.F., 2000. Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus. J CLIN ENDOCR METAB, 85(3), pp.1081-1086.

ICH Q1 A (R2), Stability testing of new drug substances and products, International Conference on Harmonization, IFPMA, Geneva, 2003.

Bauer, S., Störmer, E., Kirchheiner, J., Michael, C., Brockmöller, J. and Roots, I., 2003. Rapid and simple method for the analysis of nateglinide in human plasma using HPLC analysis with UV detection. J. Pharm. Biomed., 31(3), pp.551-555.

Jain S, Bhandari A, Purohit S. 2009 Spectrophotometric determination of nateglinide in bulk and tablet dosage forms. Asian J. Pharm: Free full text articles from Asian J Pharm. pp.3(3).

Sankalia, J.M., Sankalia, M.G., Sutariya, V.B. and Mashru, R.C., 2007. Nateglinide quantification in rabbit plasma by HPLC: optimization and application to pharmacokinetic study. J. Pharm. Biomed., 44(1), pp.196-204.

Maddi, S., Keshetty, S., Mohan Ega, C., Rao Yamasani, M. and Scriba, G.K., 2007. Development and validation of a stereoselective HPLC method for the determination of the in vitro transport of nateglinide enantiomers in rat intestine. J. Sep. Sci., 30(12), pp.1875-1880.

Asthana, S., Kaur, V., Chawla, P. and Saraf, S.A., 2010. Rapid and sensitive HPLC-UV method for simultaneous estimation of Nifedipine, Nateglinide and Lovastatin: quantitative application to polypill based synthetic ternary mixture. Int. J. Pharmtech. Res, 2, pp.682-688.

Varanasi KK, Sridhar V, Potharaju S, Shraddha R, Sivakumar SP, Sabapathi SK, Satheeshmanikandan TR, Kumar VS. 2008 Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of nateglinide, cilostazol and its active metabolite 3, 4-dehydro-cilostazol in Wistar rat plasma and its application to pharmacokinetic study. J. Chromatogr. A B.;865(1-2): pp. 91-98.

Published

04-06-2022

How to Cite

Kumari, P., Babbar, R., Singh, R., & Saini, B. (2022). Identification and characterization of degradation products of Nateglinide. International Journal of Health Sciences, 6(S2), 12894–12904. https://doi.org/10.53730/ijhs.v6nS2.8413

Issue

Section

Peer Review Articles